ArticleHuman vaccines & immunotherapeutics2012

Preclinical evaluation of the immunogenicity and safety of plasmid DNA-based prophylactic vaccines for human cytomegalovirus.

Jukka Hartikka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.